Common deal-breakers in Turkish M&A transactions usually appear before signing: a weak diligence record, an unresolved control question, a price mechanism that does not fit the accounts, or conditions that nobody can realistically satisfy. A disciplined issue list turns those points into decisions while there is still time to change the structure.
What usually stops a Turkish M&A deal?
A deal stops when the parties cannot agree who carries a known risk, how that risk changes price, or what must happen before completion. The Turkish target may be attractive, yet a missing corporate record, a disputed permit, an unworkable closing condition, or a late regulatory question can still end the process.
Start with a written red-flag log. Each entry needs an owner, an evidence source, a proposed remedy and a decision date. That prevents a material issue from being buried in a long diligence report.
Why do corporate records and authority cause friction?
Buyers need to know that the seller can transfer the shares and that the target has taken the approvals required by its own constitutional documents. Türkiye’s official investment guide states that international investors have the same rights and liabilities as local investors and that share-transfer conditions are the same. Read the Investment Office guidance on establishment and share transfers alongside the target’s records, not as a substitute for them.
Check the current registry extracts, articles, board and shareholder decisions, powers of attorney, and any transfer restrictions. A signature at the wrong level can hold up an otherwise negotiated transaction.
How can diligence findings become a price dispute?
Diligence becomes a price dispute when the purchase price assumes one working-capital, debt, tax, customer or compliance position and the evidence supports another. The practical fix is to connect each material finding to a defined adjustment, indemnity, escrow discussion, covenant, or a walk-away decision.
Do not leave terms such as debt, cash, leakage or material adverse change to a late drafting round. The accounting reference date and the permitted ordinary-course conduct need to be clear as well.
When can regulatory timing break the transaction?
Regulatory analysis belongs near the start of the timetable. Act No. 4054 covers legal transactions and conduct in the nature of mergers and acquisitions that may significantly decrease competition in Turkish markets. The Competition Authority’s official Act No. 4054 text is the primary legal starting point; transaction-specific advice determines whether an approval or filing analysis is needed.
A signing date is not a solution if a required review, sector consent, financing condition or third-party consent has no workable long-stop plan. Build the timetable around the slowest genuine dependency.
Which closing conditions deserve the most scrutiny?
A closing condition should be specific, measurable and capable of being evidenced. Vague language about satisfactory diligence, broad consents or an undefined regulatory outcome can give one side a practical veto and can make a clean completion impossible.
For a condition-by-condition approach, see Corpenza’s guide to closing conditions and completion in Turkish M&A deals. Keep the evidence package, notice mechanics and deadline next to each condition in the signing checklist.
What should parties settle before signing?
Before signing, settle the structure, price mechanics, disclosure process, interim covenants, required consents, control of communications and the remedy for a failed condition. The confidentiality perimeter also matters early because diligence often involves sensitive commercial data. Use a focused Turkish M&A NDA checklist before the data room opens.
Competition analysis is a separate workstream. Corpenza’s overview of Turkish Competition Authority merger approval thresholds can help frame the questions, while counsel should assess the actual transaction facts.
FAQ
Can a foreign buyer acquire shares in a Turkish company?
As a general framework, the official investment guide states that international investors receive equal treatment and that share-transfer conditions are the same as for local investors. Sector rules and the target’s own documents still need review.
Is a signed SPA enough to close?
No. A signed SPA may still require conditions, consents, filings, funding steps and properly authorised completion documents.
Should competition analysis wait until the end?
No. Put it on the first diligence and timetable workstream. A late issue can change the long-stop date, covenants and signing strategy.
What is the quickest way to reduce deal risk?
Turn each material diligence finding into an owner, a remedy, a document request and a date. Silence is not a remedy.
This is general information, not legal or tax advice. Transaction terms and regulatory analysis depend on the facts.
Corpenza can coordinate the corporate, compliance and execution workstreams for cross-border Turkish transactions. Contact the team to discuss the file.
